Tue, Jul 22, 2014, 8:13 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Optimer Pharmaceuticals, Inc. (OPTR) Message Board

  • chuckpalot chuckpalot Nov 4, 2011 8:43 AM Flag

    Baird Pipes In - - Raisies Price Target To $19

    Baird maintains an 'Outperform' on Optimer Pharmaceuticals (NASDAQ: OPTR) price target raised $1 to $19.

    Baird analyst says, "Dificid sales were a little better than recent consensus, but following the 9/12 positive, partial pre-announce, we sensed investors were more focused on what Q4 might look like and on underlying demand trends. The Q3 update contained constructive datapoints and clues on underlying demand trends. We came away reinforced in thinking Q4 is tracking well and fundamental growth will remain healthy."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
12.780.00(0.00%)Oct 23 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.